13. Referanser

Acem, I., van Houdt, W. J., Grünhagen, D. J., van der Graaf, W. T. A., Rueten-Budde, A. J., Gelderblom, H., Verhoef, C., & van de Sande, M. A. J. (2022). The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC. European Journal of Cancer, 165, 71-80.

Aisen, A. M., Martel, W., Braunstein, E. M., McMillin, K. I., Phillips, W. A., & Kling, T. F. (1986). MRI and CT evaluation of primary bone and soft-tissue tumors. AJR. American journal of roentgenology, 146(4), 749-756.

Al-Absi, E., Farrokhyar, F., Sharma, R., Whelan, K., Corbett, T., Patel, M., & Ghert, M. (2010). A systematic review and meta-analysis of oncologic outcomes of pre- versus postoperative radiation in localized resectable soft-tissue sarcoma. Annals of Surgical Oncology, 17(5), 1367-1374.

Albertsmeier, M., Rauch, A., Roeder, F., Hasenhütl, S., Pratschke, S., Kirschneck, M., Gronchi, A., Jebsen, N. L., ... Angele, M. K. (2018). External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 25(3), 754-767.

Alektiar, K. M., Brennan, M. F., Healey, J. H., & Singer, S. (2008). Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. Journal of Clinical Oncology, 26(20), 3440-3444.

Alektiar, K. M., Velasco, J., Zelefsky, M. J., Woodruff, J. M., Lewis, J. J., & Brennan, M. F. (2000). Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. International Journal of Radiation Oncology, Biology, Physics, 48(4), 1051-1058.

Allen, A. M., Pawlicki, T., Dong, L., Fourkal, E., Buyyounouski, M., Cengel, K., Plastaras, J., Bucci, M. K., ... Konski, A. A. (2012). An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 103(1), 8-11.

Allen, D., Cameron, R. (2017). Histopathology Specimens: Clinical, Pathological and Laboratory Aspects. Springer.

Alyas, F., James, S. L., Davies, A. M., & Saifuddin, A. (2007). The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. European Radiology, 17(10), 2675-2686.

Andreassen, A., Øyjord, T., Hovig, E., Holm, R., Flørenes, V. A., Nesland, J. M., Myklebost, O., Høie, J., ... Børresen, A. L. (1993). p53 abnormalities in different subtypes of human sarcomas. Cancer Research, 53(3), 468-71.

Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., & Shah, I. C. (1971). Radiation-induced sarcoma of bone. Cancer, 28(5), 1087-1099.

Baldini, E. H., Guadagnolo, B. A., Salerno, K. E., Chung, P., Bishop, A. J., Kalbasi, A., Miah, A., Bedi, M., ... Kirsch, D. G. (2024). Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma. Journal of Clinical Oncology, 42(36), 4240-4245.

Balosso, J., Febvey-Combes, O., Iung, A., Lozano, H., Alloh, A. S., Cornu, C., Hervé, M., Akkal, Z., ... Pommier, P. (2022). A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial. BMC Cancer, 22(1), 575.

Banfield, W., Ioakeim-Ioannidou, M., Goldberg, S., Ahmed, S., Schwab, J. H., Cote, G. M., Choy, E., Shin, J. H., ... DeLaney, T. F. (2022). Definitive high-dose, proton-based radiation for unresected mobile spine and sacral chordomas. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 171, 139-145.

Beane, J. D., Yang, J. C., White, D., Steinberg, S. M., Rosenberg, S. A., & Rudloff, U. (2014). Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Annals of Surgical Oncology, 21(8), 2484-9.

Becher, S., & Oskouei, S. (2015). PET Imaging in Sarcoma. The Orthopedic clinics of North America, 46(3), 409-15, xi.

Berger-Richardson, D., & Swallow, C. J. (2017). Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations. Cancer, 123(4), 560-567.

Berndsen, M., Renberg, S., Hølmebakk, T., Hancke, E., Puls, F., Karlsson, F., Stoldt, S., Bjerkehagen, B., ... Lindskog, S. (2023). Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy. The British journal of surgery, 110(12), 1857-1862.

Berner, K., Johannesen, T. B., Berner, A., Haugland, H. K., Bjerkehagen, B., Bøhler, P. J., & Bruland, O. S. (2015). Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncologica, 54(1), 25-33.

Berquist, T. H., Ehman, R. L., King, B. F., Hodgman, C. G., & Ilstrup, D. M. (1990). Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR. American journal of roentgenology, 155(6), 1251-1255.

Bielack, S. S., & Carrle, D. (2008). State-of-the-art approach in selective curable tumors: bone sarcoma. Annals of oncology, 19 Suppl 7, vii155-vii160.

Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., ... Euramos- investigators (2015). Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology, 33(20), 2279-87.

Bischof, D. A., Kim, Y., Dodson, R., Jimenez, M. C., Behman, R., Cocieru, A., Fisher, S. B., Groeschl, R. T., ... Pawlik, T. M. (2015). Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA surgery, 150(4), 299-306.

Bjerkehagen, B., Smeland, S., Walberg, L., Skjeldal, S., Hall, K. S., Nesland, J. M., Smastuen, M. C., Fossa, S. D., & Saeter, G. (2008). Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncologica, 47(8), 1475-1482.

Blay, J. Y., Devin, Q., Duffaud, F., Toulmonde, M., Firmin, N., Collard, O., Bompas, E., Verret, B., ... Cesne, A. L. (2024). Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial. The Lancet. Oncology, 25(9), 1163-1175.

Blay, J. Y., Schiffler, C., Bouché, O., Brahmi, M., Duffaud, F., Toulmonde, M., Landi, B., Lahlou, W., ... Le Cesne, A. (2024). A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse. Annals of oncology : official journal of the European Society for Medical Oncology, 35(12), 1157-1168.

Blay, J. Y., Serrano, C., Heinrich, M. C., Zalcberg, J., Bauer, S., Gelderblom, H., Schöffski, P., Jones, R. L., ... von Mehren, M. (2020). Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncology, 21(7), 923-934.

Bonvalot, S., Gronchi, A., Le Péchoux, C., Swallow, C. J., Strauss, D., Meeus, P., van Coevorden, F., Stoldt, S., ... Haas, R. L. (2020). Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 21(10), 1366-1377.

Bonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009). Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. Journal of Clinical Oncology, 27(1), 31-7.

Bosma, S. E., Cleven, A. H. G., & Dijkstra, P. D. S. (2019). Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled Study. Clinical Orthopaedics and Related Research, 477(7), 1548-1559.

Boye, K., Del Prever, A. B., Eriksson, M., Saeter, G., Tienghi, A., Lindholm, P., Fagioli, F., Skjeldal, S., ... Hall, K. S. (2014). High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study. Pediatric blood & cancer, 61(5), 840-5.

Brennan, B., Kirton, L., Marec-Bérard, P., Gaspar, N., Laurence, V., Martín-Broto, J., Sastre, A., Gelderblom, H., ... Wheatley, K. (2022). Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial. Lancet, 400(10362), 1513-1521.

Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Annals of Surgery, 260(3), 416-21; discussion 421-2.

Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000). Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer, 88(2), 398-406.

Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1998). Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer, 82(1), 8-34.

Callegaro, D., Barretta, F., Raut, C. P., Johnston, W., Strauss, D. C., Honoré, C., Bonvalot, S., Fairweather, M., ... Gronchi, A. (2023). New Sarculator Prognostic Nomograms for Patients with Primary Retroperitoneal Sarcoma: Case Volume Does Matter. Annals of Surgery,

Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P., Strauss, D. C., Levy, A., Griffin, A., Hayes, A. J., ... Gronchi, A. (2016). Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncology, 17(5), 671-80.

Canter, R. J., Qin, L. X., Ferrone, C. R., Maki, R. G., Singer, S., & Brennan, M. F. (2008). Why do patients with low-grade soft tissue sarcoma die?. Annals of Surgical Oncology, 15(12), 3550-3560.

Casali, P. G., Blay, J. Y., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., ... Stacchiotti, S. (2022). Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 33(1), 20-33.

Chen, L., Wu, X., Ma, X., Guo, L., Zhu, C., & Li, Q. (2017). Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis. Medicine (Baltimore), 96(6), e5913.

Chouliaras, K., Senehi, R., Ethun, C. G., Poultsides, G., Grignol, V., Clarke, C. N., Roggin, K. K., Fields, R. C., ... Votanopoulos, K. I. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of surgical oncology, 120(7), 1227-1234.

Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y. L., Yock, T. I., Ebb, D. H., Choy, E., ... Delaney, T. F. (2011). Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer, 117(19), 4522-30.

Coindre, J. M. (2006). Grading of soft tissue sarcomas: review and update. Archives of Pathology and Laboratory Medicine, 130(10), 1448-53.

Connolly, E. A., Boye, K., Bonvalot, S., Kratz, C. P., Leithner, A., Malkin, D., Messiou, C., Miah, A. B., ... Stacchiotti, S. (2025). Genetic predisposition in sarcomas: clinical implications and management. EClinicalMedicine, 83, 103203.

Constantinidou, A., Jones, R. L., Olmos, D., Thway, K., Fisher, C., Al-Muderis, O., & Judson, I. (2012). Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncologica, 51(4), 550-4.

Croce, S., Devouassoux-Shisheboran, M., Pautier, P., Ray-Coquard, I., Treilleux, I., Neuville, A., Arnould, L., Just, P. A., ... Genestie, C. (2022). Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group. Gynecologic Oncology, 167(2), 373-389.

D'Ambrosio, L., Touati, N., Blay, J. Y., Grignani, G., Flippot, R., Czarnecka, A. M., Piperno-Neumann, S., Martin-Broto, J., ... Gronchi, A. (2020). Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126(11), 2637-2647.

D'Angelo, S. P., Mahoney, M. R., Van Tine, B. A., Atkins, J., Milhem, M. M., Jahagirdar, B. N., Antonescu, C. R., Horvath, E., ... Streicher, H. (2018). Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Lancet Oncology, 19(3), 416-426.

Daisne, J. F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., & Gregoire, V. (2004). Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology, 233(1), 93-100.

Davis, A. M., O'Sullivan, B., Turcotte, R., Bell, R., Catton, C., Chabot, P., Wunder, J., Hammond, A., ... N. C. I. Canada Clinical Trial Group Randomized Trial (2005). Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 75(1), 48-53.

Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., ... Maki, R. G. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. Journal of Clinical Oncology, 37(16), 1424-1431.

DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000). Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of Surgery, 231(1), 51-58.

Demetri, G. D., Reichardt, P., Kang, Y. K., Blay, J. Y., Rutkowski, P., Gelderblom, H., Hohenberger, P., Leahy, M., ... Casali, P. G. (2013). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet, 381(9863), 295-302.

Demetri, G. D., Schöffski, P., Grignani, G., Blay, J. Y., Maki, R. G., Van Tine, B. A., Alcindor, T., Jones, R. L., ... Chawla, S. (2017). Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. Journal of Clinical Oncology, 35(30), 3433-3439.

Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., ... Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet, 368(9544), 1329-1338.

Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., Milhem, M., Elias, A., ... Patel, S. R. (2016). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology, 34(8), 786-93.

Demizu, Y., Jin, D., Sulaiman, N. S., Nagano, F., Terashima, K., Tokumaru, S., Akagi, T., Fujii, O., ... Okimoto, T. (2017). Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis. International Journal of Radiation Oncology, Biology, Physics, 98(2), 367-374.

Dickie, C. I., Haas, R., & O'Sullivan, B. (2015). Adjuvant radiation for soft tissue sarcomas. American Society of Clinical Oncology educational book, , e634-42.

Dirksen, U., Brennan, B., Le Deley, M. C., Cozic, N., van den Berg, H., Bhadri, V., Brichard, B., Claude, L., ... Hawkins, D. S. (2019). High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. Journal of Clinical Oncology, 37(34), 3192-3202.

DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., Shamberger, R. C., Sailer, S., ... Grier, H. E. (2015). Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer, 121(3), 467-75.

Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., Delcambre, C., Kalbacher, E., ... Blay, J. Y. (2019). Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncology, 20(1), 120-133.

Eaton, B. R., Schwarz, R., Vatner, R., Yeh, B., Claude, L., Indelicato, D. J., & Laack, N. (2021). Osteosarcoma. Pediatric blood & cancer, 68(Suppl 2), e28352.

Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., Shank, B., Solin, L. J., & Wesson, M. (1991). Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics, 21(1), 109-122.

Emile, J. F., Brahimi, S., Coindre, J. M., Bringuier, P. P., Monges, G., Samb, P., Doucet, L., Hostein, I., ... Aegerter, P. (2012). Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Medical Oncology, 29(3), 1765-72.

Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., & Boice, J. D. ,. (1993). Mortality from second tumors among long-term survivors of retinoblastoma. Journal of the National Cancer Institute, 85(14), 1121-1128.

Engström, K., Bergh, P., Cederlund, C. G., Hultborn, R., Willen, H., Aman, P., Kindblom, L. G., & Meis-Kindblom, J. M. (2007). Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncologica, 46(6), 838-45.

Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980). A system for the surgical staging of musculoskeletal sarcoma. Clinical Orthopaedics and Related Research, (153), 106-120.

Eriksson, M. (2010). Histology-driven chemotherapy of soft-tissue sarcoma. Annals of oncology, 21(Suppl 7), vii270-6.

Eriksson, M., Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., Bauer, S., Leinonen, M., ... Joensuu, H. (2016). Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?. European Journal of Cancer, 59, 128-133.

European and American Osteosarcoma Study Group (2012). Euramos 1. Randomised trial of the European and American osteosarcoma study group to optimise treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy London: MRC Clinical Trials Unit. Hentet fra https://www.mrcctu.ucl.ac.uk/studies/all-studies/e/euramos-1/

European Organisation for Research and Treatment of Cancer (2019-2028). Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2) [pågående studie]. (NCT04031677). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04031677

Evrard, R., Schubert, T., Paul, L., & Docquier, P. L. (2019). Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study. Orthopaedics & traumatology, surgery & research : OTSR, 105(4), 781-787.

Fein, D. A., Lee, W. R., Lanciano, R. M., Corn, B. W., Herbert, S. H., Hanlon, A. L., Hoffman, J. P., Eisenberg, B. L., & Coia, L. R. (1995). Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control?. International Journal of Radiation Oncology, Biology, Physics, 32(4), 969-976.

Feinberg, L., Srinivasan, A., Singh, J. K., Parry, M., Stevenson, J., Jeys, L., Grimer, R., Peart, F., ... Desai, A. (2018). Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. The British journal of surgery, 105(4), 401-409.

Fendler, W. P., Chalkidis, R. P., Ilhan, H., Knosel, T., Herrmann, K., Issels, R. D., Bartenstein, P., Cyran, C. C., ... Hacker, M. (2015). Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence. European Radiology, 25(8), 2214-21.

Ferrari, A., van Noesel, M. M., Brennan, B., Zanetti, I., Corradini, N., Casanova, M., Berlanga, P., Merks, J. H. M., ... Orbach, D. (2021). Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). Lancet. Child & adolescent health, 5(8), 546-558.

Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., Donati, D., Kevric, M., ... Reichardt, P. (2018). EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma. Tumori, 104(1), 30-36.

Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., Alvegard, T. A., Picci, P., ... Italian and Scandinavian Sarcoma Groups (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Journal of Clinical Oncology, 23(34), 8845-52.

Ferrari, S., Sundby Hall, K., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., Alvegard, T. A., Brach Del Prever, A., ... Smeland, S. (2011). Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Annals of Oncology, 22(5), 1221-7.

Ferraro, D., & Zalcberg, J. (2014). Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy. Therapeutic advances in medical oncology, 6(5), 222-8.

Ferron, G., Bataillon, G., Martinez, A., Chibon, F., & Valentin, T. (2024). Gynecological sarcomas, surgical management: primary, metastatic, and recurrent disease. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 34(3), 393-402.

Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., Miettinen, M., O'Leary, T. J., ... Weiss, S. W. (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. International Journal of Surgical Pathology, 10(2), 81-9.

Frebourg, T., Bajalica Lagercrantz, S., Oliveira, C., Magenheim, R., & Evans, D. G. (2020). Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. European journal of human genetics : EJHG, 28(10), 1379-1386.

Frustaci, S., Gherlinzoni, F., De, P. A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., ... Picci, P. (2001). Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. Journal of Clinical Oncology, 19(5), 1238-1247.

Fuglø, H. M., Jørgensen, S. M., Loft, A., Hovgaard, D., & Petersen, M. M. (2012). The diagnostic and prognostic value of (1)(8)F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. European journal of nuclear medicine and molecular imaging, 39(9), 1416-24.

Gannon, N. P., King, D. M., Ethun, C. G., Charlson, J., Tran, T. B., Poultsides, G., Grignol, V., Howard, J. H., ... Bedi, M. (2019). The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. Journal of surgical oncology, 120(3), 325-331.

Garcia del Muro, X. (2015). Nilotinib, imatinib, and GIST therapy. Lancet Oncology, 16(5), 483-4.

Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (2010). Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. Journal of Clinical Oncology, 28(7), 1247-53.

Georgiesh, T., Aggerholm-Pedersen, N., Schöffski, P., Zhang, Y., Napolitano, A., Bovée, J., Hjelle, Å., Tang, G., ... Boye, K. (2022). Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour. British Journal of Cancer, 127(10), 1793-1798.

Gerbers, J. G., Stevens, M., Ploegmakers, J. J., Bulstra, S. K., & Jutte, P. C. (2014). Computer-assisted surgery in orthopedic oncology. Acta orthopaedica, 85(6), 663-9.

Gerrand, C., Athanasou, N., Brennan, B., Grimer, R., Judson, I., Morland, B., Peake, D., Seddon, B., ... British Sarcoma Group (2016). UK guidelines for the management of bone sarcomas. Clinical sarcoma research, 6, 7.

Gerrand, C. H., Bell, R. S., Wunder, J. S., Kandel, R. A., O'Sullivan, B., Catton, C. N., Griffin, A. M., & Davis, A. M. (2003). The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer, 97(2), 485-492.

Gielen, J. L., De Schepper, A. M., Vanhoenacker, F., Parizel, P. M., Wang, X. L., Sciot, R., & Weyler, J. (2004). Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients. European Radiology, 14(12), 2320-2330.

Goldblum, J. R., Weiss, S. W., Folpe, A. L. (2019). Enzinger and Weiss's soft tissue tumors (7 utg.) Philadelphia: Mosby Elsevier.

Griffith, J. F., Yip, S. W. Y., Hung, E. H. Y., Fong, R. C. W., Leung, J., Ng, A. W. H., Tong, C. S. L., & Lee, R. K. L. (2020). Accuracy of ultrasound in the characterisation of deep soft tissue masses: a prospective study. European Radiology, 30(11), 5894-5903.

Grimer, R. J., Carter, S. R., Tillman, R. M., & Abudu, A. (2001). Early symptoms and diagnosis of bone tumors. The Journal of bone and joint surgery. American volume, 83-A(7), 1107-1108.

Grimer, R. J., & Sneath, R. S. (1990). Diagnosing malignant bone tumours. The Journal of bone and joint surgery. British volume, 72(5), 754-756.

Gronchi, A., Bonvalot, S., Poveda Velasco, A., Kotasek, D., Rutkowski, P., Hohenberger, P., Fumagalli, E., Judson, I. R., ... Casali, P. G. (2020). Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. JAMA surgery, 155(6), e200397.

Gronchi, A., Ferrari, S., Quagliuolo, V., Broto, J. M., Pousa, A. L., Grignani, G., Basso, U., Blay, J. Y., ... Casali, P. G. (2017). Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. The Lancet. Oncology, 18(6), 812-822.

Gronchi, A., Lo Vullo, S., Fiore, M., Mussi, C., Stacchiotti, S., Collini, P., Lozza, L., Pennacchioli, E., ... Casali, P. G. (2009). Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. Journal of Clinical Oncology, 27(1), 24-30.

Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., ... Stacchiotti, S. (2021). Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Annals of oncology, 32(11), 1348-1365.

Gronchi, A., Miceli, R., Allard, M. A., Callegaro, D., Le Péchoux, C., Fiore, M., Honoré, C., Sanfilippo, R., ... Bonvalot, S. (2015). Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Annals of Surgical Oncology, 22(5), 1447-54.

Gronchi, A., Palmerini, E., Quagliuolo, V., Martin Broto, J., Lopez Pousa, A., Grignani, G., Brunello, A., Blay, J. Y., ... Casali, P. G. (2020). Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. Journal of Clinical Oncology, 38(19), 2178-2186.

Gronchi, A., Strauss, D. C., Miceli, R., Bonvalot, S., Swallow, C. J., Hohenberger, P., Van Coevorden, F., Rutkowski, P., ... Raut, C. P. (2016). Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Annals of Surgery, 263(5), 1002-9.

Grosso, F., Sanfilippo, R., Virdis, E., Piovesan, C., Collini, P., Dileo, P., Morosi, C., Tercero, J. C., ... Casali, P. G. (2009). Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Annals of oncology, 20(8), 1439-1444.

Guadagnolo, B. A., Bassett, R. L., Mitra, D., Farooqi, A., Hempel, C., Dorber, C., Willis, T., Wang, W. L., ... Bishop, A. J. (2022). Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. The Lancet. Oncology, 23(12), 1547-1557.

Gyorki, D. E., & Brennan, M. F. (2014). Management of recurrent retroperitoneal sarcoma. Journal of surgical oncology, 109(1), 53-9.

Haas, R. L., Delaney, T. F., O'Sullivan, B., Keus, R. B., Le Pechoux, C., Olmi, P., Poulsen, J. P., Seddon, B., & Wang, D. (2012). Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where?. International Journal of Radiation Oncology, Biology, Physics, 84(3), 572-80.

Habrand, J. L., Schneider, R., Alapetite, C., Feuvret, L., Petras, S., Datchary, J., Grill, J., Noel, G., ... Sainte-Rose, C. (2008). Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies. International Journal of Radiation Oncology, Biology, Physics, 71(3), 672-5.

Haibach, H., Farrell, C., & Dittrich, F. J. (1985). Neoplasms arising in Paget's disease of bone: a study of 82 cases. American Journal of Clinical Pathology, 83(5), 594-600.

Hall, K. S., Bruland Ø, S., Bjerkehagen, B., Lidbrink, E., Jebsen, N., Hagberg, H., Papworth, K., Hagberg, O., ... Eriksson, M. (2020). Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clinical sarcoma research, 10(1), 22.

Hall, K. S., Bruland Ø, S., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., Hansson, L., Hagberg, H., ... Eriksson, M. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). European Journal of Cancer, 99, 78-85.

Hartmann, J. T., Kopp, H. G., Gruenwald, V., Piperno-Neumann, S., Kunitz, A., Hofheinz, R., Mueller, L., Geissler, M., ... Mayer, F. (2020). Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma. European Journal of Cancer, 124, 152-160.

Hawkins, M. M., Wilson, L. M., Burton, H. S., Potok, M. H., Winter, D. L., Marsden, H. B., & Stovall, M. A. (1996). Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. Journal of the National Cancer Institute, 88(5), 270-278.

Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., Sabbatini, P., Tong, W., ... Spriggs, D. R. (2002). Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Journal of Clinical Oncology, 20(12), 2824-2831.

Hesla, A. C., Tsagozis, P., Jebsen, N., Zaikova, O., Bauer, H., & Brosjö, O. (2016). Improved Prognosis for Patients with Ewing Sarcoma in the Sacrum Compared with the Innominate Bones: The Scandinavian Sarcoma Group Experience. The Journal of bone and joint surgery. American volume, 98(3), 199-210.

Heslin, M. J., Lewis, J. J., Nadler, E., Newman, E., Woodruff, J. M., Casper, E. S., Leung, D., & Brennan, M. F. (1997). Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. Journal of Clinical Oncology, 15(8), 2832-2839.

Higuchi, T., Yamamoto, N., Nishida, H., Hayashi, K., Takeuchi, A., Kimura, H., Miwa, S., Inatani, H., ... Tsuchiya, H. (2017). Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen. International orthopaedics, 41(10), 2189-2197.

Hompland, I., Boye, K., Wiedswang, A. M., Papakonstantinou, A., Røsok, B., Joensuu, H., & Bruland, Ø. (2024). Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study. Acta oncologica (Stockholm, Sweden), 63, 288-293.

Hompland, I., Ferrari, S., Bielack, S., Palmerini, E., Hall, K. S., Picci, P., Hecker-Nolting, S., Donati, D. M., ... Smeland, S. (2021). Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. European Journal of Cancer, 151, 150-158.

Hongtao, L., Hui, Z., Bingshun, W., Xiaojin, W., Zhiyu, W., Shuier, Z., Aina, H., Yuanjue, S., ... Yang, Y. (2012). 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis. Surgical Oncology, 21(4), e165-70.

Huang, T., Li, F., Yan, Z., Ma, Y., Xiong, F., Cai, X., Zhang, Q., Liu, F., & Dong, J. (2018). Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. Medicine (Baltimore), 97(48), e13457.

Hug, E. B., Adams, J., Fitzek, M., De Vries, A., & Munzenrider, J. E. (2000). Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. International Journal of Radiation Oncology, Biology, Physics, 47(4), 979-84.

Hung, E. H. Y., Griffith, J. F., Yip, S. W. Y., Ivory, M., Lee, J. C. H., Ng, A. W. H., & Tong, C. S. L. (2020). Accuracy of ultrasound in the characterization of superficial soft tissue tumors: a prospective study. Skeletal Radiology, 49(6), 883-892.

Hung, J., & Anderson, R. (1997). p53: functions, mutations and sarcomas. Acta orthopaedica Scandinavica Suppl, 273, 68-73.

Huvos, A. G., Butler, A., & Bretsky, S. S. (1983). Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer, 52(8), 1489-1495.

Hwang, J. P., Lim, I., Kong, C. B., Jeon, D. G., Byun, B. H., Kim, B. I., Choi, C. W., & Lim, S. M. (2016). Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. PloS One, 11(4), e0153281.

Hølmebakk, T., Bjerkehagen, B., Hompland, I., Stoldt, S., & Boye, K. (2019). Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. The British journal of surgery, 106(4), 419-426.

Hølmebakk, T., Hompland, I., Bjerkehagen, B., Stoldt, S., Bruland Ø, S., Hall, K. S., & Boye, K. (2018). Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study. Annals of Surgical Oncology, 25(5), 1133-1139.

Hølmebakk, T., Wiedswang, A. M., Meza-Zepeda, L. A., Hompland, I., Lobmaier, I. V. K., Berner, J. M., Stoldt, S., & Boye, K. (2021). Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach. Annals of Surgical Oncology, 28(11), 6837-6845.

Iacobellis, G., Leggio, A., Salzillo, C., Lucà, S., Ortega-Ruiz, R., & Marzullo, A. (2025). Analysis and Historical Evolution of Paediatric Bone Tumours: The Importance of Early Diagnosis in the Detection of Childhood Skeletal Malignancies. Cancers, 17(3)

Igaki, H., Tokuuye, K., Okumura, T., Sugahara, S., Kagei, K., Hata, M., Ohara, K., Hashimoto, T., ... Akine, Y. (2004). Clinical results of proton beam therapy for skull base chordoma. International Journal of Radiation Oncology, Biology, Physics, 60(4), 1120-6.

Igarashi, K., Yamamoto, N., Shirai, T., Hayashi, K., Nishida, H., Kimura, H., Takeuchi, A., & Tsuchiya, H. (2014). The long-term outcome following the use of frozen autograft treated with liquid nitrogen in the management of bone and soft-tissue sarcomas. The bone & joint journal, 96-B(4), 555-61.

ISG, SSG (2002). An italian - scandinavian treatment protocol for metastatic and pelvic osteosarcoma (ISG/SSG II) Bologna; Lund: Italian sarcoma group (ISG) & Scandinavian sarcoma group and oncologic center (SSG).

Italiano, A., Mir, O., Mathoulin-Pelissier, S., Penel, N., Piperno-Neumann, S., Bompas, E., Chevreau, C., Duffaud, F., ... Blay, J. Y. (2020). Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. Lancet Oncology, 21(3), 446-455.

Jamshidi, K., Naghizadeh, H., Shooroki, K. K., Arabzadeh, A., Karami, M., Khosravi, E., Arefpour, A. M., & Khabiri, S. S. (2025). Optimizing local control in Ewing sarcoma: a critical discussion of radiotherapy and surgical approaches with proposed decision-making algorithm; a narrative review. Radiation oncology, 20(1), 165.

Jebsen, N. L., Bruland, Ø. S., Eriksson, M., Engellau, J., Turesson, I., Folin, A., Trovik, C. S., & Hall, K. S. (2011). Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. International Journal of Radiation Oncology, Biology, Physics, 81(5), 1359-66.

Jebsen, N. L., Trovik, C. S., Bauer, H. C., Rydholm, A., Monge, O. R., Hall, K. S., Alvegard, T., & Bruland, O. S. (2008). Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. International Journal of Radiation Oncology, Biology, Physics, 71(4), 1196-1203.

Jian, B. J., Bloch, O. G., Yang, I., Han, S. J., Aranda, D., Tihan, T., & Parsa, A. T. (2010). Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. Journal of Neuro-Oncology, 98(1), 101-108.

Jingu, K., Tsujii, H., Mizoe, J. E., Hasegawa, A., Bessho, H., Takagi, R., Morikawa, T., Tonogi, M., ... Organizing Committee for the Working Group for Head-and-Neck, C. (2012). Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 82(5), 2125-31.

Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human Pathology, 39(10), 1411-1419.

Joensuu, H., Eriksson, M., Collan, J., Balk, M. H., Leyvraz, S., & Montemurro, M. (2015). Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 116(2), 233-8.

Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J. T., Pink, D., Schutte, J., Ramadori, G., Hohenberger, P., ... Reichardt, P. (2012). One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA, 307(12), 1265-72.

Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., ... Reichardt, P. (2016). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology, 34(3), 244-50.

Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hermes, B., Schütte, J., Cameron, S., Hohenberger, P., ... Reichardt, P. (2020). Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up. JAMA oncology, 6(8), 1241-1246.

Joensuu, H., Vehtari, A., Riihimaki, J., Nishida, T., Steigen, S. E., Brabec, P., Plank, L., Nilsson, B., ... Rutkowski, P. (2012). Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncology, 13(3), 265-74.

Joensuu, H., Wardelmann, E., Eriksson, M., Reichardt, A., Hall, K. S., Schütte, J., Cameron, S., Hohenberger, P., ... Reichardt, P. (2023). KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(17), 3313-3319.

Joensuu, H., Wardelmann, E., Sihto, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., ... Reichardt, P. (2017). Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. JAMA oncology, 3(5), 602-609.

Jones, R. L., Serrano, C., von Mehren, M., George, S., Heinrich, M. C., Kang, Y. K., Schöffski, P., Cassier, P. A., ... Bauer, S. (2021). Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. European Journal of Cancer, 145, 132-142.

Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J. Y., Kerst, J. M., Sufliarsky, J., ... van der Graaf, W. T. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncology, 15(4), 415-23.

Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J. E., Miyamoto, T., Kato, H., Yamada, S., ... Working Group for the Bone Soft Tissue Sarcomas (2002). Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. Journal of Clinical Oncology, 20(22), 4466-71.

Kang, Y. K., Ryu, M. H., Yoo, C., Ryoo, B. Y., Kim, H. J., Lee, J. J., Nam, B. H., Ramaiya, N., ... Demetri, G. D. (2013). Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncology, 14(12), 1175-82.

Kepka, L., DeLaney, T. F., Suit, H. D., & Goldberg, S. I. (2005). Results of radiation therapy for unresected soft-tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics, 63(3), 852-859.

Kinge, B., Tranheim, R. S., & Eide, N. A. (2004). Retinoblastom--arvelig øyekreft hos barn. Tidsskrift for den Norske Legeforening, 124(2), 183-5.

Koch, R., Gelderblom, H., Haveman, L., Brichard, B., Jürgens, H., Cyprova, S., van den Berg, H., Hassenpflug, W., ... Dirksen, U. (2022). High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma. Journal of Clinical Oncology, 40(21), 2307-2320.

Koontz, B. F., Clough, R. W., & Halperin, E. C. (2006). Palliative radiation therapy for metastatic Ewing sarcoma. Cancer, 106(8), 1790-1793.

Kransdorf, M. J. (2009). Society of skeletal radiology 2008 annual meeting. Skeletal Radiology, 38(1), 97-100.

Kransdorf, M. J., & Murphey, M. D. (2000). Radiologic evaluation of soft-tissue masses: a current perspective. AJR. American journal of roentgenology, 175(3), 575-587.

Kransdorf, M. J., Murphey, M. D. (2006). Imaging of soft tissue tumors (2 utg.) Philadelphia, Pa.: Lippincott Williams & Wilkins.

Kubo, T., Furuta, T., Johan, M. P., & Ochi, M. (2016). Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. European Journal of Cancer, 58, 104-11.

Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., van den Berg, H., Dirksen, U., ... Jürgens, H. (2010). Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. Journal of Clinical Oncology, 28(20), 3284-91.

Lakkaraju, A., Sinha, R., Garikipati, R., Edward, S., & Robinson, P. (2009). Ultrasound for initial evaluation and triage of clinically suspicious soft-tissue masses. Clinical Radiology, 64(6), 615-21.

Lansu, J., Bovée, J., Braam, P., van Boven, H., Flucke, U., Bonenkamp, J. J., Miah, A. B., Zaidi, S. H., ... Haas, R. L. (2021). Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA oncology, 7(1), e205865.

Lavie, O., Barnett-Griness, O., Narod, S. A., & Rennert, G. (2008). The risk of developing uterine sarcoma after tamoxifen use. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 18(2), 352-6.

Le Cesne, A., Antoine, E., Spielmann, M., Le Chevalier, T., Brain, E., Toussaint, C., Janin, N., Kayitalire, L., ... et al. (1995). High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. Journal of Clinical Oncology, 13(7), 1600-8.

Le Cesne, A., Blay, J. Y., Judson, I., Van, O. A., Verweij, J., Radford, J., Lorigan, P., Rodenhuis, S., ... Nielsen, O. S. (2005). Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. Journal of Clinical Oncology, 23(3), 576-584.

Le Cesne, A., Ray-Coquard, I., Bui, B. N., Adenis, A., Rios, M., Bertucci, F., Duffaud, F., Chevreau, C., ... Blay, J. Y. (2010). Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncology, 11(10), 942-9.

Lee, C. T., Bilton, S. D., Famiglietti, R. M., Riley, B. A., Mahajan, A., Chang, E. L., Maor, M. H., Woo, S. Y., ... Smith, A. R. (2005). Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?. International Journal of Radiation Oncology, Biology, Physics, 63(2), 362-72.

Leray, H., Angeles, M. A., Daix, M., Martinez, A., Martínez Gómez, C., & Ferron, G. (2021). How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 31(10), 1382-1383.

Levernes, S., Johannessen, D. C. (2003). Volum og doser ved strålebehandling: definisjoner, retningslinjer for bruk, dokumentasjon og rapportering Østerås: Hentet fra https://dsa.no/publikasjoner/stralevernrapport-12-2003-volum-og-doser-ved-stralebehandling/straalevernrapport-2003-12-volum-og-doser-ved-straalebehandling-definisjoner-retningslinjer-dokumentasjon-rapportering.pdf

Lewis, J. J., Leung, D., Woodruff, J. M., & Brennan, M. F. (1998). Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Annals of Surgery, 228(3), 355-365.

Li, F. P., & Fraumeni, J. F. ,. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Annals of Internal Medicine, 71(4), 747-752.

Li, G. Z., Fairweather, M., Wang, J., Orgill, D. P., Bertagnolli, M. M., & Raut, C. P. (2017). Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival. Annals of Surgery, 265(4), 814-820.

Li, Y. J., Dai, Y. L., Cheng, Y. S., Zhang, W. B., & Tu, C. Q. (2016). Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis. European Journal of Surgical Oncology, 42(8), 1103-14.

Lim, H. J., Johnny Ong, C. A., Tan, J. W., & Ching Teo, M. C. (2019). Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Critical Reviews in Oncology/Hematology, 143, 1-13.

Liu, F., Zhang, Q., Zhou, D., & Dong, J. (2019). Effectiveness of (18)F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies. BMC Cancer, 19(1), 323.

Liu, J., Hudkins, P. G., Swee, R. G., & Unni, K. K. (1987). Bone sarcomas associated with Ollier's disease. Cancer, 59(7), 1376-1385.

Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., Spinnato, P., Donati, D., ... Boye, K. (2019). Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta Oncologica, 58(1), 124-128.

Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Eriksson, M., ... Ferrari, S. (2012). Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. Annals of oncology, 23(11), 2970-6.

Ma, L. D., McCarthy, E. F., Bluemke, D. A., & Frassica, F. J. (1998). Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. AJR. American journal of roentgenology, 170(5), 1251-1258.

Macpherson, R. E., Pratap, S., Tyrrell, H., Khonsari, M., Wilson, S., Gibbons, M., Whitwell, D., Giele, H., ... Hassan, A. B. (2018). Retrospective audit of 957 consecutive (18)F-FDG PET-CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma. Clinical sarcoma research, 8, 9.

Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A. L., ... Strong, L. C. (1992). Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. New England Journal of Medicine, 326(20), 1309-1315.

Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982). The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of bone and joint surgery. American volume, 64(8), 1121-1127.

Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., Hook, J. M., Arndt, C., ... Whelan, J. S. (2016). Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology, 17(10), 1396-1408.

Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., Bentzen, S. M., Nam, J., & Deasy, J. O. (2010). Use of normal tissue complication probability models in the clinic. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S10-9.

Mattke, M., Ohlinger, M., Bougatf, N., Harrabi, S., Wolf, R., Seidensaal, K., Welzel, T., Röder, F., ... Debus, J. (2023). Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 199(2), 160-168.

Menu-Branthomme, A., Rubino, C., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Dondon, M. G., Hardiman, C., Vassal, G., ... de Vathaire, F. (2004). Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. International Journal of Cancer, 110(1), 87-93.

Metser, U., Kulanthaivelu, R., Salawu, A., Razak, A., Mak, V., Li, X., Langer, D. L., MacCrostie, P., & Singnurkar, A. (2023). [(18)F]FDG PET/CT in the Initial Staging and Restaging of Soft-Tissue or Bone Sarcoma in Patients with Negative or Equivocal Findings for Metastases or Limited Recurrence on Conventional Work-up: Results of a Prospective Multicenter Registry. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 64(9), 1371-1377.

Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., Ferguson, W. S., Gebhardt, M. C., ... Children's Oncology, G. (2008). Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Journal of Clinical Oncology, 26(4), 633-8.

Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Seminars in Diagnostic Pathology, 23(2), 70-83.

Milano, M. T., Constine, L. S., & Okunieff, P. (2007). Normal tissue tolerance dose metrics for radiation therapy of major organs. Seminars in Radiation Oncology, 17(2), 131-140.

Miller, T. T. (2008). Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology, 246(3), 662-674.

Mir, O., Cropet, C., Toulmonde, M., Cesne, A. L., Molimard, M., Bompas, E., Cassier, P., Ray-Coquard, I., ... Pazogist study group of the French Sarcoma Groupe-Groupe d'Etude des Tumeurs Osseuses (2016). Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial. Lancet Oncology, 17(5), 632-41.

Miralbell, R., Lomax, A., Cella, L., & Schneider, U. (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. International Journal of Radiation Oncology, Biology, Physics, 54(3), 824-9.

Mizumoto, M., Murayama, S., Akimoto, T., Demizu, Y., Fukushima, T., Ishida, Y., Oshiro, Y., Numajiri, H., ... Sakurai, H. (2018). Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan. Cancer medicine, 7(5), 1870-1874.

Morgan, E. A., Kozono, D. E., Wang, Q., Mery, C. M., Butrynski, J. E., Baldini, E. H., George, S., Nascimento, A. F., & Raut, C. P. (2012). Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Annals of Surgical Oncology, 19(12), 3801-8.

Moser, R. P. ,., & Madewell, J. E. (1987). An approach to primary bone tumors. Radiologic Clinics of North America, 25(6), 1049-1093.

Moulton, J. S., Blebea, J. S., Dunco, D. M., Braley, S. E., Bisset, G. S. ,., & Emery, K. H. (1995). MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR. American journal of roentgenology, 164(5), 1191-1199.

Mucciarini, C., Rossi, G., Bertolini, F., Valli, R., Cirilli, C., Rashid, I., Marcheselli, L., Luppi, G., & Federico, M. (2007). Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer, 7, 230.

Murray, E. M., Werner, D., Greeff, E. A., & Taylor, D. A. (1999). Postradiation sarcomas: 20 cases and a literature review. International Journal of Radiation Oncology, Biology, Physics, 45(4), 951-961.

NCCN (2024). Bone Cancer (NCCN Guidelines Version 1.2024). Plymouth Meeting, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1418

NCCN (2024). Soft Tissue Sarcoma (NCCN Guidelines Version 4.2024). Plymouth Meeting, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1464

Noel, G., Feuvret, L., Calugaru, V., Dhermain, F., Mammar, H., Haie-Meder, C., Ponvert, D., Hasboun, D., ... Mazeron, J. J. (2005). Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncologica, 44(7), 700-8.

Noel, G., Habrand, J. L., Jauffret, E., de Crevoisier, R., Dederke, S., Mammar, H., Haie-Meder, C., Pontvert, D., ... Mazeron, J. J. (2003). Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlentherapie und Onkologie, 179(4), 241-8.

O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., Wunder, J., Kandel, R., ... Zee, B. (2002). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet, 359(9325), 2235-2241.

O'Sullivan, B., Wylie, J., Catton, C., Gutierrez, E., Swallow, C. J., Wunder, J., Gullane, P., Neligan, P., & Bell, R. (1999). The local management of soft tissue sarcoma. Seminars in Radiation Oncology, 9(4), 328-348.

Oberlin, O., Rey, A., Desfachelles, A. S., Philip, T., Plantaz, D., Schmitt, C., Plouvier, E., Lejars, O., ... Michon, J. (2006). Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. Journal of Clinical Oncology, 24(24), 3997-4002.

Oslo University Hospital (2016-2022). SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST [pågående studie]. (NCT02924714). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02924714

Oslo University Hospital (2021-2034). Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma [pågående studie]. (NCT04776525). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04776525

Palassini, E., Baldi, G. G., Sulfaro, S., Barisella, M., Bianchi, G., Campanacci, D., Fiore, M., Gambarotti, M., ... Stacchiotti, S. (2024). Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group. Cancer Treatment Reviews, 126, 102722.

Palmerini, E., Colangeli, M., Nanni, C., Fanti, S., Marchesi, E., Paioli, A., Picci, P., Cambioli, S., ... Ferrari, S. (2017). The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. European journal of nuclear medicine and molecular imaging, 44(2), 215-223.

Palmerini, E., Jones, R. L., Marchesi, E., Paioli, A., Cesari, M., Longhi, A., Meazza, C., Coccoli, L., ... Ferrari, S. (2016). Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone. BMC Cancer, 16, 280.

Parker, W. H., Fu, Y. S., & Berek, J. S. (1994). Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstetrics and Gynecology, 83(3), 414-418.

Pasquali, S., Pizzamiglio, S., Touati, N., Litiere, S., Marreaud, S., Kasper, B., Gelderblom, H., Stacchiotti, S., ... Gronchi, A. (2019). The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. European Journal of Cancer, 109, 51-60.

Patel, D. B., & Matcuk, G. R. ,. J. (2018). Imaging of soft tissue sarcomas. Chinese clinical oncology, 7(4), 35.

Pautier, P., Italiano, A., Piperno-Neumann, S., Chevreau, C., Penel, N., Firmin, N., Boudou-Rouquette, P., Bertucci, F., ... Duffaud, F. (2022). Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Lancet Oncology, 23(8), 1044-1054.

Pautier, P., Italiano, A., Piperno-Neumann, S., Chevreau, C., Penel, N., Firmin, N., Boudou-Rouquette, P., Bertucci, F., ... Duffaud, F. (2024). Doxorubicin-Trabectedin with Trabectedin Maintenance in Leiomyosarcoma. The New England journal of medicine, 391(9), 789-799.

Penel, N., Bui, B. N., Bay, J. O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., Kerbrat, P., Fournier, C., ... Blay, J. Y. (2008). Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. Journal of Clinical Oncology, 26(32), 5269-5274.

Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008). A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer, 113(3), 573-581.

Petasnick, J. P., Turner, D. A., Charters, J. R., Gitelis, S., & Zacharias, C. E. (1986). Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology, 160(1), 125-133.

Pisters, P. W., O'Sullivan, B., & Maki, R. G. (2007). Evidence-based recommendations for local therapy for soft tissue sarcomas. Journal of Clinical Oncology, 25(8), 1003-1008.

Pisters, P. W. T. (2002). Hamilton: Decker.

Rakheja, R., Makis, W., Skamene, S., Nahal, A., Brimo, F., Azoulay, L., Assayag, J., Turcotte, R., & Hickeson, M. (2012). Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR. American journal of roentgenology, 198(6), 1409-16.

Ray-Coquard, I., Casali, P. G., Croce, S., Fennessy, F. M., Fischerova, D., Jones, R., Sanfilippo, R., Zapardiel, I., ... Friedlander, M. (2024). ESGO/EURACAN/GCIG guidelines for the management of patients with uterine sarcomas. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 34(10), 1499-1521.

Riedel, R. F., Larrier, N., Dodd, L., Kirsch, D., Martinez, S., & Brigman, B. E. (2009). The clinical management of chondrosarcoma. Current Treatment Options in Oncology, 10(1-2), 94-106.

Roberge, D., Vakilian, S., Alabed, Y. Z., Turcotte, R. E., Freeman, C. R., & Hickeson, M. (2012). FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma. Sarcoma, 2012, 960194.

Robertson, E. G., & Baxter, G. (2011). Tumour seeding following percutaneous needle biopsy: the real story!. Clinical Radiology, 66(11), 1007-14.

Roeder, F. (2020). Radiation Therapy in Adult Soft Tissue Sarcoma-Current Knowledge and Future Directions: A Review and Expert Opinion. Cancers, 12(11)

Rombi, B., DeLaney, T. F., MacDonald, S. M., Huang, M. S., Ebb, D. H., Liebsch, N. J., Raskin, K. A., Yeap, B. Y., ... Yock, T. I. (2012). Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. International Journal of Radiation Oncology, Biology, Physics, 82(3), 1142-8.

Roohani, S., Aggerholm-Pedersen, N., Eckert, F., Ashleigh Guadagnolo, B., Kirsch, D. G., Miah, A. B., Salerno, K. E., Sangalli, C., ... Haas, R. L. (2026). ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall - Endorsed by ASTRO. Radiotherapy and Oncology, 220, 111535.

Rosenberg, A. E., Nielsen, G. P., Keel, S. B., Renard, L. G., Fitzek, M. M., Munzenrider, J. E., & Liebsch, N. J. (1999). Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. The American journal of surgical pathology, 23(11), 1370-8.

Rowbotham, E., Bhuva, S., Gupta, H., & Robinson, P. (2012). Assessment of referrals into the soft tissue sarcoma service: evaluation of imaging early in the pathway process. Sarcoma, 2012, 781723.

Salerno, K. E., Alektiar, K. M., Baldini, E. H., Bedi, M., Bishop, A. J., Bradfield, L., Chung, P., DeLaney, T. F., ... Guadagnolo, B. A. (2021). Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline. Practical Radiation Oncology, 11(5), 339-351.

Salunke, A. A., Chen, Y., Tan, J. H., Chen, X., Khin, L. W., & Puhaindran, M. E. (2014). Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis. The bone & joint journal, 96-B(10), 1396-403.

Sambri, A., Bianchi, G., Longhi, A., Righi, A., Donati, D. M., Nanni, C., Fanti, S., & Errani, C. (2019). The role of 18F-FDG PET/CT in soft tissue sarcoma. Nuclear Medicine Communications, 40(6), 626-631.

Scandinavian Sarcoma Group, Oncologic Center Lund (2009). Centralized Registration of Sarcoma Patients in Scandinavia SSG VII:4 Lund: Scandinavian Sarcoma Group. Hentet fra http://www.ocsyd.se/VP-verksamhet/Hud%20mjukdel%20skelett/Euroboss1.pdf

Schöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., Grignani, G., Camargo, V., ... Patel, S. R. (2016). Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet, 387(10028), 1629-37.

Schöffski, P., Mir, O., Kasper, B., Papai, Z., Blay, J. Y., Italiano, A., Benson, C., Kopeckova, K., ... Gelderblom, H. (2020). Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'. European Journal of Cancer, 134, 62-74.

Schwartz, H. S., Zimmerman, N. B., Simon, M. A., Wroble, R. R., Millar, E. A., & Bonfiglio, M. (1987). The malignant potential of enchondromatosis. The Journal of bone and joint surgery. American volume, 69(2), 269-274.

Seddon, B., Strauss, S. J., Whelan, J., Leahy, M., Woll, P. J., Cowie, F., Rothermundt, C., Wood, Z., ... Beare, S. (2017). Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncology, 18(10), 1397-1410.

Serrano, C., Bauer, S., Blay, J. Y., Casali, P. G., Cicala, C. M., Dei Tos, A. P., Digklia, A., Gelderblom, H., ... Bovée, J. (2025). Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review. JAMA oncology, 11(12), 1527-1537.

Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schoffski, P., Collin, F., Pandite, L., ... Blay, J. Y. (2009). Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). Journal of Clinical Oncology, 27(19), 3126-32.

Smith, L. M., & Donaldson, S. S. (1991). Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. Oncology (Williston Park, N.Y.), 5(5), 135-41; discussion 142.

Smith, M. J., Ridgway, P. F., Catton, C. N., Cannell, A. J., O'Sullivan, B., Mikula, L. A., Jones, J. J., & Swallow, C. J. (2014). Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 110(1), 165-71.

Stacchiotti, S., Tortoreto, M., Bozzi, F., Tamborini, E., Morosi, C., Messina, A., Libertini, M., Palassini, E., ... Casali, P. G. (2013). Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clinical cancer research : an official journal of the American Association for Cancer Research, 19(18), 5192-201.

Stanborough, R., Demertzis, J. L., Wessell, D. E., Lenchik, L., Ahlawat, S., Baker, J. C., Banks, J., Caracciolo, J. T., ... Beaman, F. D. (2022). ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update. Journal of the American College of Radiology : JACR, 19(11 suppl), S374-s389.

Stoeckle, E., Coindre, J. M., Bonvalot, S., Kantor, G., Terrier, P., Bonichon, F., Nguyen Bui, B., & French Federation of Cancer Centers Sarcoma, G. (2001). Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer, 92(2), 359-68.

Stoldt, H. S., Geraghty, J. G. (1999). London: Royal Society of Medicine Press.

Strander, H., Bauer, H. C., Brosjö, O., Fernberg, J. O., Kreicbergs, A., Nilsonne, U., Silfverswärd, C., Signomklao, T., & Söderlund, V. (1995). Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study. Acta Oncologica, 34(6), 877-880.

Strander, H., & Einhorn, S. (1977). Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. International Journal of Cancer, 19(4), 468-473.

Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., Bielack, S., Blay, J. Y., ... ERN PaedCan (2021). Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology, 32(12), 1520-1536.

Suit, H., Kooy, H., Trofimov, A., Farr, J., Munzenrider, J., DeLaney, T., Loeffler, J., Clasie, B., ... Paganetti, H. (2008). Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 86(2), 148-53.

Sundby Hall, K., Bruland Ø, S., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., Hansson, L., Hagberg, H., ... Eriksson, M. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). European journal of cancer (Oxford, England : 1990), 99, 78-85.

Swallow, C. J., Strauss, D. C., Bonvalot, S., Rutkowski, P., Desai, A., Gladdy, R. A., Gonzalez, R., Gyorki, D. E., ... Gronchi, A. (2021). Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Annals of Surgical Oncology, 28(12), 7873-7888.

Swanson, E. L., Indelicato, D. J., Louis, D., Flampouri, S., Li, Z., Morris, C. G., Paryani, N., & Slopsema, R. (2012). Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. International Journal of Radiation Oncology, Biology, Physics, 83(5), 1549-57.

Tawbi, H. A., Burgess, M., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Hu, J., D'Angelo, S., Attia, S., ... Patel, S. (2017). Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncology, 18(11), 1493-1501.

Tehranzadeh, J., Mnaymneh, W., Ghavam, C., Morillo, G., & Murphy, B. J. (1989). Comparison of CT and MR imaging in musculoskeletal neoplasms. Journal of Computer Assisted Tomography, 13(3), 466-472.

Thomas, H., & Timmermann, B. (2020). Paediatric proton therapy. The British journal of radiology, 93(1107), 20190601.

Thoresen, S. O. (1992). Li-Fraumeni-syndromet og p53-genet. Tidsskrift for den Norske Legeforening, 112(7), 887-889.

Toguchida, J., Yamaguchi, T., Dayton, S. H., Beauchamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., ... Sasaki, M. S. (1992). Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. New England Journal of Medicine, 326(20), 1301-8.

Toulmonde, M., Bonvalot, S., Méeus, P., Stoeckle, E., Riou, O., Isambert, N., Bompas, E., Jafari, M., ... Italiano, A. (2014). Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Annals of oncology, 25(3), 735-742.

Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., ... Greene, M. H. (2006). Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute, 98(1), 15-25.

Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., Johansson, I., Sampo, M., ... Alvegard, T. A. (2017). The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta orthopaedica, 88(3), 341-347.

Trovik, C. S., Bauer, H. C., Berlin, O., Tukiainen, E., Erlanson, M., Gustafson, P., Klepp, R., Saeter, G., & Wahlstrom, O. (2001). Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica, 72(2), 160-166.

Trovik, L. H., Ovrebo, K., Almquist, M., Haugland, H. K., Rissler, P., Eide, J., Engellau, J., Monge, O. R., ... Jebsen, N. L. (2014). Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients. Acta Oncologica, 53(9), 1165-72.

Tsuchiya, T., Sekine, K., Hinohara, S., Namiki, T., Nobori, T., & Kaneko, Y. (2000). Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genetics and Cytogenetics, 120(2), 91-98.

Uhl, M., Edler, L., Jensen, A. D., Habl, G., Oelmann, J., Röder, F., Jackel, O., Debus, J., & Herfarth, K. (2014). Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol. Radiation oncology, 9, 100.

University of Birmingham (2020-2030). FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma (FaR-RMS) [pågående studie]. (NCT04625907). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04625907

van der Burg, S. J. C., Reijers, S. J. M., Kuijpers, A., Heimans, L., Scholten, A. N., Haas, R. L. M., Boven, H. V., Kolff, W. M., ... van Houdt, W. J. (2024). Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study. Breast, 78, 103825.

van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., Schoffski, P., Aglietta, M., ... Hohenberger, P. (2012). Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379(9829), 1879-86.

Van Glabbeke, M., Verweij, J., Judson, I., & Nielsen, O. S. (2002). Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas. European Journal of Cancer, 38(4), 543-9.

van Houdt, W. J., NS, I. J., Marjolein Schrijver, A., Huis In 't Veld, E., Thway, K., Jones, R. L., Fotiadis, N., Hayes, A. J., ... Smith, M. J. F. (2021). Oncological Outcome After Diagnostic Biopsies in Gastrointestinal Stromal Tumors: A Retrospective Cohort Study. Annals of Surgery, 274(6), e1093-e1098.

van Houdt, W. J., Raut, C. P., Bonvalot, S., Swallow, C. J., Haas, R., & Gronchi, A. (2019). New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Current opinion in oncology, 31(4), 310-316.

van Praag, V. M., Rueten-Budde, A. J., Jeys, L. M., Laitinen, M. K., Pollock, R., Aston, W., van der Hage, J. A., Dijkstra, P. D. S., ... Fiocco, M. (2017). A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC). European Journal of Cancer, 83, 313-323.

Van Winkle, P., Angiolillo, A., Krailo, M., Cheung, Y. K., Anderson, B., Davenport, V., Reaman, G., & Cairo, M. S. (2005). Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatric blood & cancer, 44(4), 338-47.

Villano, A. M., Zeymo, A., Chan, K. S., Shara, N., & Al-Refaie, W. B. (2020). Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion. Journal of the American College of Surgeons, 230(1), 151-160.e2.

Vincenzi, B., Napolitano, A., Fiocco, M., Mir, O., Rutkowski, P., Blay, J. Y., Reichardt, P., Joensuu, H., ... Casali, P. G. (2021). Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 28(8), 1672–1679.

Wang, D., Bosch, W., Roberge, D., Finkelstein, S. E., Petersen, I., Haddock, M., Chen, Y. L., Saito, N. G., ... DeLaney, T. F. (2011). RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. International Journal of Radiation Oncology, Biology, Physics, 81(4), e525-8.

Weatherall, P. T. (1995). Benign and malignant masses. MR imaging differentiation. Magnetic Resonance Imaging Clinics of North America, 3(4), 669-694.

Weber, D. C., Murray, F. R., Correia, D., Bolsi, A., Frei-Welte, M., Pica, A., Lomax, A. J., Schneider, R., & Bachtiary, B. (2017). Pencil beam scanned protons for the treatment of patients with Ewing sarcoma. Pediatric blood & cancer, 64(12)

Weber, D. C., Trofimov, A. V., Delaney, T. F., & Bortfeld, T. (2004). A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. International Journal of Radiation Oncology, Biology, Physics, 58(5), 1596-606.

Welch, H. G., & Dossett, L. A. (2025). Routine Surveillance for Cancer Metastases - Does It Help or Harm Patients?. The New England journal of medicine, 392(17), 1667-1670.

Westra, W. H. . R. H., Phelps, T. H., Isacson, C. (2003). Surgical pathology dissection: an illustrated guide. Springer.

Whelan, J., Le Deley, M. C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., Hawkins, D. S., Amler, S., ... Oberlin, O. (2018). High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. Journal of Clinical Oncology, 36(31), 3110-3119.

WHO Classification of Tumours Editorial Board (2020). Soft Tissue and Bone Tumours (5 utg.) Lyon: IARC.

WHO Classification of Tumours Editorial Board (2020). Female Genital Tumours (5 utg.) Lyon: IARC.

Wick, M. R., Siegal, G. P., Unni, K. K., McLeod, R. A., & Greditzer, H. G. ,. (1981). Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience. The American journal of surgical pathology, 5(1), 47-59.

Widhe, B., & Widhe, T. (2000). Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. The Journal of bone and joint surgery. American volume, 82(5), 667-674.

Wilky, B. A., Trucco, M. M., Subhawong, T. K., Florou, V., Park, W., Kwon, D., Wieder, E. D., Kolonias, D., ... Trent, J. C. (2019). Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. Lancet Oncology, 20(6), 837-848.

Wittekind, C., Compton, C. C., Greene, F. L., & Sobin, L. H. (2002). TNM residual tumor classification revisited. Cancer, 94(9), 2511-6.

Wolfson, A. H., Benedetto, P. W., Mnaymneh, W., Moffat, F. L., Robinson, D. S., Boyer, C., Raub, W. A. ,., Duncan, R. C., & Markoe, A. M. (1998). Does a radiation dose-response relation exist concerning survival of patients who have soft-tissue sarcomas of the extremities? Radiation dose-response relation for soft-tissue sarcomas. American Journal of Clinical Oncology, 21(3), 270-274.

Woll, P. J., Reichardt, P., Le Cesne, A., Bonvalot, S., Azzarelli, A., Hoekstra, H. J., Leahy, M., Van Coevorden, F., ... EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee (2012). Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncology, 13(10), 1045-54.

Xiang, M., Chang, D. T., & Pollom, E. L. (2020). Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy. Cancer, 126(15), 3560-3568.

Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., ... Rosenberg, S. A. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Journal of Clinical Oncology, 16(1), 197-203.

Yap, J., Chuba, P. J., Thomas, R., Aref, A., Lucas, D., Severson, R. K., & Hamre, M. (2002). Sarcoma as a second malignancy after treatment for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 52(5), 1231-1237.

Zagars, G. K., & Ballo, M. T. (2003). Significance of dose in postoperative radiotherapy for soft tissue sarcoma. International Journal of Radiation Oncology, Biology, Physics, 56(2), 473-481.

Zaikova, O., Sundby Hall, K., Styring, E., Eriksson, M., Trovik, C. S., Bergh, P., Bjerkehagen, B., Skorpil, M., ... Bauer, H. C. (2015). Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience. Journal of surgical oncology, 112(8), 853-60.

Zalcberg, J. R., Verweij, J., Casali, P. G., Le Cesne, A., Reichardt, P., Blay, J. Y., Schlemmer, M., Van Glabbeke, M., ... Australasian Gastrointestinal Trials Group (2005). Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. European Journal of Cancer, 41(12), 1751-7.

Zhou, H., Coffin, C. M., Perkins, S. L., Tripp, S. R., Liew, M., & Viskochil, D. H. (2003). Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. The American journal of surgical pathology, 27(10), 1337-1345.